Management of congenital adrenal hyperplasia in childhood.


PURPOSE OF REVIEW Congenital adrenal hyperplasia (CAH) can present management challenges to the pediatric clinician. Glucocorticoid replacement remains the cornerstone of treatment; however, there are new formulations and delivery mechanisms being studied. Clinicians continue to discuss the optimal treatment of patients from the prenatal stage, through… (More)
DOI: 10.1097/MED.0b013e32835a1a1b